Dan Brennan
Stock Analyst at TD Securities
(3.87)
# 587
Out of 4,873 analysts
107
Total ratings
48.84%
Success rate
10.01%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $56 → $60 | $49.99 | +20.02% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $90.90 | +21.01% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $2.23 | +12.11% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $68.28 | +8.38% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $51.17 | +68.07% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $171.87 | +1.82% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $148.40 | +68.46% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $39.66 | +76.50% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $91.52 | +93.40% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $96.39 | +49.39% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $346.80 | +18.22% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $197.47 | +59.52% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $117.64 | +36.01% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $5.05 | +494.06% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $13.46 | +130.31% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $404.37 | +62.72% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $42.63 | +19.63% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.28 | +917.44% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $7.23 | +176.63% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $10.89 | +193.85% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $232.93 | +134.41% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $2.20 | +218.18% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.20 | +1,150.00% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $148.54 | +56.19% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,185.18 | -25.75% | 3 | Oct 7, 2020 |
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $49.99
Upside: +20.02%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $90.90
Upside: +21.01%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.23
Upside: +12.11%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $68.28
Upside: +8.38%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $51.17
Upside: +68.07%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $171.87
Upside: +1.82%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $148.40
Upside: +68.46%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $39.66
Upside: +76.50%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $91.52
Upside: +93.40%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $96.39
Upside: +49.39%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $346.80
Upside: +18.22%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $197.47
Upside: +59.52%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $117.64
Upside: +36.01%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $5.05
Upside: +494.06%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $13.46
Upside: +130.31%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $404.37
Upside: +62.72%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $42.63
Upside: +19.63%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.28
Upside: +917.44%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $7.23
Upside: +176.63%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $10.89
Upside: +193.85%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $232.93
Upside: +134.41%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $2.20
Upside: +218.18%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.20
Upside: +1,150.00%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $148.54
Upside: +56.19%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,185.18
Upside: -25.75%